Lisa Baumann Kreuziger
Overview
Explore the profile of Lisa Baumann Kreuziger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kreuziger L, Keenan M, Dykhoff H, Hall M, Campbell K, Cahill E, et al.
Am J Med Qual
. 2025 Feb;
40(2):38-43.
PMID: 39930618
Guidelines for diagnosing pulmonary embolism (PE) start with a risk assessment using a pretest probability (PTP) tool, followed by D-dimer testing or computed tomography pulmonary angiography (CTPA) depending on risk....
2.
Hamulyak E, Wang T, Kreuziger L, Iyengar V, Carney B, Hoeben A, et al.
Haematologica
. 2025 Feb;
PMID: 39911106
Not available.
3.
Corrao K, Umpierrez A, Treml A, Szabo A, Michaelis L, Runaas L, et al.
Haematologica
. 2025 Jan;
PMID: 39882645
Not available.
4.
Fatola A, Fatola A, Evans M, Brown J, Davis E, Johnson A, et al.
Blood Adv
. 2024 Dec;
9(2):417-424.
PMID: 39626301
Immune thrombotic thrombocytopenic purpura (iTTP) is a chronically relapsing disorder caused by autoantibody-mediated deficiency of ADAMTS13. Rituximab is frequently administered to prevent relapses, but whether the durability of rituximab effect...
5.
Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J, et al.
Blood
. 2024 Nov;
PMID: 39576992
Thromboembolic complication is common in severe coronavirus disease (COVID-19), leading to an investigation into the presence of prothrombotic antibodies akin to those found in heparin-induced thrombocytopenia (HIT). In a study...
6.
Gulick R, Pau A, Daar E, Evans L, Gandhi R, Tebas P, et al.
Ann Intern Med
. 2024 Sep;
177(11):1547-1557.
PMID: 39348691
Description: In March 2020, the White House Coronavirus Task Force determined that clinicians in the United States needed expert treatment guidelines to optimally manage patients with COVID-19, a potentially life-threatening...
7.
Kosiborod M, Windsor S, Vardeny O, Berger J, Reynolds H, Boumakis S, et al.
Lancet Diabetes Endocrinol
. 2024 Sep;
12(10):725-734.
PMID: 39250922
Background: Patients hospitalised for COVID-19 are at risk for multiorgan failure and death. Sodium-glucose co-transporter-2 (SGLT2) inhibitors provide cardiovascular and kidney protection in patients with cardiometabolic conditions and could provide...
8.
Roh D, Poyraz F, Mao E, Shen Q, Kansara V, Cottarelli A, et al.
J Am Heart Assoc
. 2024 Jul;
13(14):e035524.
PMID: 38979830
Background: Baseline anemia is associated with poor intracerebral hemorrhage (ICH) outcomes. However, underlying drivers for anemia and whether anemia development after ICH impacts clinical outcomes are unknown. We hypothesized that...
9.
Zantek N, Steiner M, Teruya J, Kreuziger L, Raffini L, Muszynski J, et al.
Pediatr Crit Care Med
. 2024 Jul;
25(7 Suppl 1):e35-e43.
PMID: 38959358
Objectives: To derive systematic review informed, modified Delphi consensus regarding monitoring and replacement of specific coagulation factors during pediatric extracorporeal membrane oxygenation (ECMO) support for the Pediatric ECMO Anticoagulation CollaborativE....
10.
Alexander P, Bembea M, Cashen K, Cheifetz I, Dalton H, Himebauch A, et al.
Pediatr Crit Care Med
. 2024 Jul;
25(7):643-675.
PMID: 38959353
Objectives: To present recommendations and consensus statements with supporting literature for the clinical management of neonates and children supported with extracorporeal membrane oxygenation (ECMO) from the Pediatric ECMO Anticoagulation CollaborativE...